TD Cowen lowered the firm’s price target on Alphabet (GOOG) to $210 from $220 and keeps a Buy rating on the shares. The firm updated its model ...

TD Cowen analyst Tyler Van Buren maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report) yesterday. The company’s shares ...

Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell — along with CFO Bob McMahon — will participate in a fireside chat at TD Cowen's 45th Annual Health Care ...

On Thursday, TD Cowen initiated coverage on Disc Medicine (NASDAQ:IRON), giving the stock a Buy rating. Currently trading at $54.46, the company maintains a market capitalization of $1.83 billion ...

The Washington-based software giant has canceled leases in the US totaling “a couple of hundred megawatts,” or about two huge data centers, according to a report from TD Cowen analysts ...

Investing.com -- TD Cowen lift its target on Mondelez (NASDAQ:MDLZ) International by $14 to $71, also raised its 2026 per share profit estimate, amid a 19% decline in cocoa spot prices this year ...

Microsoft Corp. has canceled some leases for U.S. data center capacity, according to TD Cowen, raising broader concerns over whether it’s securing more AI computing capacity than it needs in the ...

TD Cowen projects that with Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) continuing their dominance, global sales of the GLP-1 class of weight loss/obesity drugs could reach $139B by 2030 ...

Rion Aesthetics, a company at the forefront of exosome technology in the aesthetics industry, today announced its participation as a panelist at TD Cowen’s 2nd Annual Glowing Ahead: Beauty ...